Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Rayonier Advanced Materials Inc.
RYAM
NYSE·Basic Materials·Chemicals·Mkt cap $521.3M
$7.36
▼ -4.79%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$3.35 - $11.85
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 88.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Vertically integrated production with established global supply chains across multiple continents
- Diversified product portfolio serving resilient end-markets including personal care, pharmaceuticals, and industrial applications
- Sustainable cellulose sourcing and production capabilities aligned with growing demand for eco-friendly materials
- Nearly 100-year operational history providing manufacturing expertise and customer relationships
Bear Case
1 risk
- Above-average volatility (beta 1.8).
Growth
Stable outlook
Rising demand for specialty cellulose in pharmaceutical and cosmetic formulations
Value
Deep value opportunity - significant discount to Commodity Chemicals peers
Momentum
Falling
-27.2% over 3m
Quality
Thin
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying RYAM right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 4, 2026
MAY 5, 2026
Reported EPS of -$0.61 vs -$0.62 consensus (+1.7% surprise). Revenue of $319.0M vs $302.6M expected (+5.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+1.7%
Next: Aug 4, 2026
Revenue trend · last 8Q
—
—
+0%
-8%
-19%
-12%
-1%
-10%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$419.0M
$401.1M
$422.5M
$356.0M
$340.0M
$353.0M
$417.0M
$319.1M
Margins · last 8Q
Gross
—
Operating
—
Profit
-25.7%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: RBC Capital · Mar 5, 2026